Marie Wikström Lindholm
Chief Tech/Sci/R&D Officer bij SILENCE THERAPEUTICS PLC
Profiel
Marie Wikström Lindholm is currently the Director at Oligonucleotide Therapeutics Society, Inc. since 2022.
She is also the Chief Scientific Officer at Silence Therapeutics Plc since 2017.
Previously, she worked as an Assistant Professor at the University of Lund from 1999 to 2000.
Dr. Lindholm holds a doctorate degree from the University of Uppsala.
Actieve functies van Marie Wikström Lindholm
| Bedrijven | Functie | Begin |
|---|---|---|
| SILENCE THERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 01-12-2023 |
Oligonucleotide Therapeutics Society, Inc.
 Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The private company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | Director/Board Member | 18-01-2022 |
Eerdere bekende functies van Marie Wikström Lindholm
| Bedrijven | Functie | Einde |
|---|---|---|
| University of Lund | Corporate Officer/Principal | 01-01-2000 |
Opleiding van Marie Wikström Lindholm
| University of Uppsala | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SILENCE THERAPEUTICS PLC | Commercial Services |
| Bedrijven in privébezit | 1 |
|---|---|
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The private company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | Commercial Services |
